NSC 42834 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK2-V617F, and JAK2-WT.
Molecular Weight
344.45
Molecular Formula
C23H24N2O
Targets
JAK2-V617F: 28 μM; JAK2-WT: 15 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
NSC 42834 can be employed to study the inhibition of JAK2 signaling pathways.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.